CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 44136-44355
Annnotations
CORD-19-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T417 | 0-219 | Sentence | denotes | BabyGenes, Inc, in partnership with ArcherDX, Inc., has developed a targeted next-generation sequencing (NGS) assay based on Anchored Multiplex PCR (AMP) to detect all mutations currently reported in the CFTR2 database. |
CORD-19_Custom_license_subset
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T417 | 0-219 | Sentence | denotes | BabyGenes, Inc, in partnership with ArcherDX, Inc., has developed a targeted next-generation sequencing (NGS) assay based on Anchored Multiplex PCR (AMP) to detect all mutations currently reported in the CFTR2 database. |